Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PDSB PDS Biotechnology > Detailed Quotes

PDSB PDS Biotechnology

3.700
+0.420+12.80%
Close 10/04 16:00 ET
High
3.730
Open
3.350
Turnover
949.52K
Low
3.340
Pre Close
3.280
Volume
267.76K
Market Cap
105.30M
P/E(TTM)
Loss
52wk High
14.800
Shares
28.46M
P/E(Static)
Loss
52wk Low
2.890
Float Cap
95.13M
Bid/Ask %
-61.29%
Historical High
17.850
Shs Float
25.71M
Volume Ratio
1.63
Historical Low
0.615
Dividend TTM
--
Div Yield TTM
--
P/B
2.05
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.04%
Amplitude
11.89%
Avg Price
3.546
Lot Size
1
Float Cap
95.13M
Bid/Ask %
-61.29%
Historical High
17.850
Shs Float
25.71M
Volume Ratio
1.63
Historical Low
0.615
Dividend TTM
--
P/B
2.05
Dividend LFY
--
Turnover Ratio
1.04%
Amplitude
11.89%
Avg Price
3.546
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.
CEO: Mr. Frank Bedu-Addo, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...